Letter by Zhao et al Regarding Article, “Association Between Serum Bilirubin, Lipid Levels, and Prevalence of Femoral and Carotid Atherosclerosis: A Population-Based Cross-Sectional Study”
- 1 April 2023
- journal article
- letter
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 43 (4) , E121-E122
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Association Between Serum Bilirubin, Lipid Levels, and Prevalence of Femoral and Carotid Atherosclerosis: A Population-Based Cross-Sectional StudyArteriosclerosis, Thrombosis, and Vascular Biology, 2023
- Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real studyEuropean Journal of Cancer, 2022
- Cholesterol-induced toxicity: An integrated view of the role of cholesterol in multiple diseasesCell Metabolism, 2021
- High-Density Lipoprotein as a Therapeutic TargetJAMA, 2007
- Epidemiologic evidence for high-density lipoprotein cholesterol as a risk factor for coronary artery diseaseThe American Journal of Cardiology, 2001
- High density lipoprotein as a protective factor against coronary heart diseaseThe American Journal of Medicine, 1977
- Conversion of Indirect-to Direct-Reacting Bilirubin in vivoScience, 1958